{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:51:07Z","timestamp":1762375867675,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nmd.2014.06.438","type":"journal-article","created":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T18:15:37Z","timestamp":1403979337000},"page":"982-985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Screening for late-onset Pompe disease in Finland"],"prefix":"10.1016","volume":"24","author":[{"given":"Johanna","family":"Palmio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Auranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9597-4603","authenticated-orcid":false,"given":"Sari","family":"Kiuru-Enari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervi","family":"L\u00f6fberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Bodamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarne","family":"Udd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2014.06.438_b0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"unstructured":"Leslie N, Tinkle BT. Glycogen storage disease type II (Pompe Disease) In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews\u2122 [Internet]. Seattle (WA): Seattle, University of Washington; 1993\u20132013. 2007 Aug 31 [updated 2013 May 09].","key":"10.1016\/j.nmd.2014.06.438_b0010"},{"key":"10.1016\/j.nmd.2014.06.438_b0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2014.06.438_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","article-title":"Pompe disease: design, methodology, and early findings from the Pompe Registry","volume":"103","author":"Byrne","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2014.06.438_b0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"AANEM consensus committee on late-onset Pompe disease: AANEM consensus committee on late-onset Pompe disease. consensus treatment recommendations for late-onset Pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2014.06.438_b0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.gim.0000217781.66786.9b","article-title":"Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease","volume":"8","author":"Zhang","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2014.06.438_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2012.09.012","article-title":"Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening","volume":"908","author":"Mechtler","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.nmd.2014.06.438_b0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counseling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2014.06.438_b0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nmd.2014.06.438_b0050","first-page":"709","article-title":"Pompe\u2019s disease or glycogen storage disease","volume":"98","author":"Vanto","year":"1982","journal-title":"Duodecim"},{"key":"10.1016\/j.nmd.2014.06.438_b0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mus.21291","article-title":"A novel mutation of the GAA gene in a Finnish late-onset Pompe disease patient: clinical phenotype and follow-up with enzyme replacement therapy","volume":"40","author":"Korpela","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2014.06.438_b0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cccn.2004.04.009","article-title":"Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper","volume":"347","author":"Chamoles","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.nmd.2014.06.438_b0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2007.09.006","article-title":"Pompe disease diagnostic working group methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting","volume":"93","author":"Winchester","year":"2008","journal-title":"Mol Genet Metab"},{"doi-asserted-by":"crossref","unstructured":"Bodamer OA, Dajnoki A. Diagnosing lysosomal storage disorders: Pompe disease. Curr Protoc Hum Genet 2012 Oct; Chapter 17, Unit 17.","key":"10.1016\/j.nmd.2014.06.438_b0070","DOI":"10.1002\/0471142905.hg1711s75"},{"key":"10.1016\/j.nmd.2014.06.438_b0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2013.08.005","article-title":"Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies","volume":"110","author":"Preisler","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2014.06.438_b0080","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/jmg.32.10.836-a","article-title":"Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients","volume":"32","author":"Kroos","year":"1995","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2014.06.438_b0085","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jmg.30.10.857","article-title":"Disease gene mapping in isolated human populations: the example of Finland","volume":"30","author":"de la Chapelle","year":"1993","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2014.06.438_b0090","first-page":"109","article-title":"Hereditary diseases in Finland; rare flora in rare soil","volume":"5","author":"Norio","year":"1973","journal-title":"Ann Clin Res"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661400604X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661400604X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:02:34Z","timestamp":1760774554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089661400604X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S096089661400604X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2014.06.438","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for late-onset Pompe disease in Finland","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2014.06.438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}